15-Year-Old Ebola Vaccine Could Now Speed Outbreak Response
TL;DR
A promising rVSV-based Ebola vaccine developed in 2011 has never progressed to human trials due to funding gaps, but with the Bundibugyo outbreak in Congo intensifying, researchers and WHO are rushing to test and manufacture it, aiming to use ring vaccination despite logistical and regulatory hurdles.
- The Most Promising Ebola Vaccine Has Been Sitting on the Shelf for 15 Years WIRED
- Scientists Race to Test Treatments as Ebola Outbreak Widens The New York Times
- Why existing vaccines won’t help this Ebola outbreak National Geographic
- Ebola Bundibugyo vaccine candidates could enter Phase 1 trials as early as July Reuters
- The vaccines and treatments being developed for Ebola outbreak The Japan Times
Want the full story? Read the original reporting
Read on WIRED